Latest Strategic Partnerships News

NoviqTech has entered a strategic partnership with Evercity to integrate their platforms and expand blockchain-enabled carbon market solutions, targeting emerging markets like East Africa.

ReNerve Limited has reported a remarkable 260% increase in quarterly sales following its successful IPO, alongside strategic distribution deals in Hong Kong and the Middle East. The company is poised for further growth with upcoming clinical data and product developments.

PhosCo has achieved critical milestones with the approval of its Gassaat Phosphate Project and a strategic MoU with the Tunisian Government and EBRD, setting the stage for a major drilling campaign and positioning itself as a future global fertilizer supplier.

Artrya Limited reports solid progress on its FDA 510(k) application and secures a A$5 million capital raise, positioning itself for imminent commercial rollout in the US healthcare sector.

Cokal Limited has partnered with Cratus Group to establish an Infrastructure Joint Venture aimed at significantly expanding coal transport capacity and efficiency, supporting a ramp-up in metallurgical coal production at the BBM mine.

Victory Metals advances its North Stanmore Heavy Rare Earth Project with a strategic offtake MOU signed with Sumitomo Corporation and a significant upgrade to its mineral resource estimate, reinforcing its position in the critical rare earths sector.

Neurizon Therapeutics reports encouraging 8-month interim results for its ALS drug NUZ-001, secures Orphan Medicinal Product Designation in Europe, and raises $885,000 through a share placement, maintaining a robust $14 million cash position.

Galan Lithium Limited has announced a substantial 150% increase in its Candelas Mineral Resource to 1.6 Mt LCE, lifting its total Hombre Muerto West resource to 9.5 Mt LCE and securing a spot among the world’s top 10 lithium projects.

CurveBeam AI Limited reported a remarkable 150% increase in device purchase orders in Q2 FY25, driven by strong demand for its HiRise™M platform and a new commercial agreement with Stryker. The company is advancing validation of its Enhanced HiRise™ for robotic surgical systems, despite a regulatory delay for its BMD SaaS module.

Microba Life Sciences reports a remarkable 102% revenue increase in Q2 FY25, driven by strong sales of its MetaXplore test in Australia and promising early traction in the UK. The company also advances its therapeutic pipeline with key clinical milestones.

Microba Life Sciences reported a robust Q2 FY25 with revenue more than doubling year-on-year, driven by strong sales of its MetaXplore microbiome test in Australia and promising early adoption in the UK.

Universal Biosensors is expanding its handheld testing portfolio with the upcoming AQUASCOUT water sensor and growing sales of its FDA-approved Xprecia Prime blood coagulation device, targeting multi-billion-dollar markets.